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Brief Definit ive Report
NK cells are innate lymphocytes that kill virally 
infected and malignant cells. Their importance 
for the control of disease is highlighted by the 
susceptibility of NK-deficient patients to viral 
infections (Orange, 2006). NK cells also play a 
role preventing the development and progres-
sion of cancer: cancer deaths are less frequent in 
patients who have higher levels of natural cyto-
toxic activity (Imai et al., 2000), and stem cell 
transplant–derived NK cells are an important 
determinant of survival after radiotherapy for 
acute myeloid leukemia (Velardi et al., 2012).
NK cells develop in bone marrow from com-
mon lymphoid progenitors (CLPs; Kondo et al., 
1997), which derive from lymphoid-primed 
multipotent progenitors (LMPPs; Adolfsson et al., 
2005). NK progenitors (NKPs) were origi-
nally defined as Lin NK1.1 DX5 CD122+ 
(Rosmaraki et al., 2001), but the progenitor fre-
quency in this population is only 1 in 12, so 
the majority of these cells are not NKPs. Re-
cently, the NKP phenotype has been refined, 
identifying populations that contain NKPs at 
a frequency of one in two (Carotta et al., 2011; 
Fathman et al., 2011).
Several transcription factors that affect NK 
production have been identified, and the pheno-
types of their knockouts suggest that these genes 
are required at different stages in development. 
Both immature and mature NK (iNK and mNK, 
respectively) numbers are reduced in the absence 
of Ets1 (Ramirez et al., 2012), T-bet (Townsend 
et al., 2004; Gordon et al., 2012), and E4bp4 
(Gascoyne et al., 2009; Kamizono et al., 2009), 
suggesting that they act relatively early in de-
velopment. Eomes (Gordon et al., 2012), Id2 
(Yokota et al., 1999; Boos et al., 2007), IRF2 
(Lohoff et al., 2000; Taki et al., 2005), MEF 
(Lacorazza et al., 2002), and Tox (Aliahmad et al., 
2010) act later, whereas NK cells in CEBP 
(Kaisho et al., 1999) and Gata3 (Samson et al., 
2003) knockout mice reach maturity but have 
functional defects. Transcription factor networks 
controlling the production of some immune lin-
eages have already been described in detail, but 
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The transcription factor E4bp4 (Nfil3) is essential for natural killer (NK) cell production. 
Here, we show that E4bp4 is required at the NK lineage commitment point when NK pro-
genitors develop from common lymphoid progenitors (CLPs) and that E4bp4 must be ex-
pressed at the CLP stage for differentiation toward the NK lineage to occur. To elucidate 
the mechanism by which E4bp4 promotes NK development, we identified a central core of 
transcription factors that can rescue NK production from E4bp4/ progenitors, suggesting 
that they act downstream of E4bp4. Among these were Eomes and Id2, which are expressed 
later in development than E4bp4. E4bp4 binds directly to the regulatory regions of both 
Eomes and Id2, promoting their transcription. We propose that E4bp4 is required for 
commitment to the NK lineage and promotes NK development by directly regulating the 
expression of the downstream transcription factors Eomes and Id2.
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and mNK numbers are severely reduced in its absence, con-
sistent with a role early in NK development (Gascoyne et al., 
2009; Kamizono et al., 2009). Therefore, E4bp4 is a good can-
didate for a factor required at the NK lineage commitment 
point, and we might expect to find a network of transcription 
although there has been some progress in defining the relation-
ships between various transcription factors required for NK 
development, the precise hierarchy is still poorly understood.
E4bp4 (Nfil3) is a bZIP transcription factor with diverse 
roles in immune cell function (Male et al., 2012). Both iNK 
Figure 1. E4bp4/ mice, but not other NK-deficient strains, lack NKPs. (A) Flow cytometry gating strategy for identification of pre-NKP and 
rNKP in bone marrow from E4bp4+/+ (top) and E4bp4/ (bottom) mice. Frequency of gated population is shown. (B–D) The graphs show the frequency of 
LMPPs, CLPs, pre-NKPs, and rNKPs as a percentage of the total lineage-negative population in bone marrow, the frequency of iNK and mNK as a percent-
age of the scatter gate, and absolute numbers of all NK developmental intermediates. (B) E4bp4+/+ and E4bp4/; six mice per genotype. (C) Rag/ and 
Rag/Il15ra/; three mice per genotype. (D) T-bet+/+ and T-bet/; three mice per genotype. Error bars show SEM. **, P < 0.005.
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factor to be identified as essential for the production of NK-
committed progenitors.
In the absence of E4bp4, IL-15–responsive CD122+ NKPs 
fail to develop (Fig. 1 A), suggesting that E4bp4 is required for 
expression of the IL-15 receptor and thus that E4bp4 acts up-
stream of IL-15 signaling. Furthermore, the absence of E4bp4 
perturbs NK cell development earlier than the absence of 
IL-15 signaling (Fig. 1 C). These surprising results suggest that 
E4bp4 acts before IL-15, which has previously been considered 
the definitive factor required for the production of NK cells. 
The suggestion that E4bp4 expression is required for detection 
of IL-15 is not necessarily inconsistent with our previous pro-
posal that E4bp4 acts downstream of IL-15 signaling (Gascoyne 
et al., 2009) because it is possible that E4bp4 acts both up- and 
downstream of IL-15, forming a self-reinforcing positive feed-
back loop that drives commitment to the NK lineage.
E4bp4 is expressed before Eomes, Id2, and T-bet
Our finding that E4bp4 is required for NKP production 
whereas T-bet is not suggests that E4bp4 may act before T-bet 
in NK development. To investigate this and to compare ex-
pression of E4bp4 with that of transcription factors for which 
no knockout is available on the C57BL/6 background, we 
sorted cells at various stages of NK cell differentiation from 
wild-type bone marrow and measured their expression of 
transcription factor mRNAs. E4bp4 transcript was detectable 
in both LMPPs and CLPs, increasing at later stages of NK 
development (Fig. 2 A). Eomes (Fig. 2 B), Id2 (Fig. 2 C), and 
T-bet (Fig. 2 D) were barely detectable in LMPPs and CLPs. 
Therefore, E4bp4 is expressed earlier in development than 
Eomes, Id2, and T-bet.
NK production requires E4bp4 expression in CLPs
The requirement of E4bp4 for the production of CLP-derived 
NK developmental intermediates, together with the early ex-
pression of E4bp4 in LMPPs and CLPs, led us to speculate that 
factors downstream of E4bp4. Here, we show that E4bp4 is 
essential for the development of NK-committed progenitor 
cells from CLPs and identify several transcription factors, no-
tably Eomes and Id2, that act downstream of it.
RESULTS AND DISCUSSION
E4bp4 is required for the development of NKPs
It has previously been reported that NKPs, but not iNK, are 
present in E4bp4/ bone marrow, leading to the suggestion 
that E4bp4 is required at the NKP to iNK transition (Gascoyne 
et al., 2009; Kamizono et al., 2009), but this work used the 
original working definition of NKPs (Rosmaraki et al., 2001). 
We sought to investigate whether the newly defined pre-NKPs 
(Lin 2B4+ CD27+ CD127+ Flt3 CD122) and rNKPs (Lin 
2B4+ CD27+ CD127+ Flt3 CD122+; Fathman et al., 2011) 
were still present in the absence of E4bp4. Both pre-NKPs and 
rNKPs were present in E4bp4+/+ bone marrow (Fig. 1 A, top), 
but their frequency was reduced by 7.8- and 10.6-fold, respec-
tively, in E4bp4/ bone marrow (Fig. 1 A, bottom). In con-
trast, the frequency of LMPPs (Lin Sca1+ ckit+ Flt3+ CD127) 
and CLPs (Lin Sca1int ckitint Flt3+ CD127+) was unchanged 
(Fig. 1 B). Absolute numbers of pre-NKPs and rNKPs were re-
duced in E4bp4/ bone marrow, but LMPPs and CLPs were 
unchanged (Fig. 1 B).
To determine whether NKPs are reduced in other condi-
tions in which NK production is perturbed, we examined two 
other strains of mice that have severe NK deficiencies: the 
Il15ra knockout cannot mediate IL-15 signaling, which is criti-
cal for NK production (Lodolce et al., 1998), whereas the T-bet 
(Tbx21) knockout lacks a transcription factor crucial for NK 
cell development (Townsend et al., 2004; Gordon et al., 2012). 
Pre-NKP and rNKP frequencies and absolute numbers were 
unaffected in the absence of both IL-15 signaling (Fig. 1 C) and 
T-bet (Fig. 1 D), indicating that a reduction in NKP fre-
quency does not occur in all situations in which NK devel-
opment is affected. E4bp4, then, is so far the only transcription 
Figure 2. E4bp4 transcript is expressed before those of 
Eomes, T-bet, and Id2. (A) Real-time PCR analysis of E4bp4 
expression by LMPP, CLP, pre-NKP, rNKP, iNK, and mNK cells 
sorted from wild-type bone marrow. (B–D) Expression of Eomes (B),  
Id2 (C), and T-bet (D). (A–D) Data are representative of four (A) or 
three independent experiments (B–D). Error bars show SEM.
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is required for NK lineage commitment, we took a similar 
approach, restoring E4bp4 expression in purified E4bp4/ 
CLPs and examining whether this was sufficient to reestablish 
NK cell development.
We first sorted CLPs from E4bp4/ bone marrow and 
cultured them in lymphocyte-inducing conditions, transducing 
at 48 h with either E4bp4 or empty vector (negative control) 
before moving to NK-inducing conditions (Gascoyne et al., 
2009). Cells transduced with empty vector did not produce 
NK cells, but neither did those transduced with E4bp4 (not 
depicted). Because transduction occurred after 48 h in culture, 
we reasoned that to transduce CLPs, as opposed to cells merely 
derived from CLPs, it might be necessary to initiate the culture 
with an earlier developmental stage and allow the cells to dif-
ferentiate into CLPs. Indeed, by starting the cultures with 
sorted LMPPs (Fig. 3, A and B), we found that at the time of 
transduction, the cells exhibited a CLP phenotype (Fig. 3 C). 
By taking this approach, the cells that were transduced at 48 h 
were confirmed CLPs.
Transduced cells (Fig. 3 D) were examined for their ex-
pression of the NK marker NK1.1. CLPs transduced with 
E4bp4 had given rise to NK cells, but those transduced with 
vector control had not (Fig. 3, E and F). The ability of E4bp4 
to rescue NK production from E4bp4/ cells when its ex-
pression is restored in a pure CLP population indicates that 
E4bp4 can act at the CLP stage, just before NK cell lineage 
commitment. The proposal that E4bp4 is required specifically 
at the lineage commitment point is supported by the recent 
report that E4bp4 is not required for the maintenance of cells 
that are already committed to the NK lineage (Firth et al., 
2013). In agreement with our finding that E4bp4 is required 
for the production of NK-committed progenitors in vivo 
(Fig. 1 B), this in vitro approach provides further evidence 
that E4bp4 controls the production of NKPs from CLPs.
Identification of transcription factors  
that complement E4bp4 function
In light of these indications that E4bp4 acts at the earliest pos-
sible point in NK development, we sought to define its rela-
tionship with other transcription factors that are likely to act 
downstream. We generated a panel of candidates to be regu-
lated by E4bp4. Eomes, T-bet, Id2, Gata3, Gfi1, Ets1, CEBP, 
IRF2, MEF, and Tox were included because of the phenotypes 
of their knockouts. Batf3 acts downstream of E4bp4 in CD8+ 
cDC development (Kashiwada et al., 2011), so we wished to 
see whether it acts similarly in NK development. We included 
Ifi205, Foxh1, Lztfl1, and Pegasus (Ikzf5) because they were 
expressed at reduced levels in E4bp4/ lineage-depleted 
bone marrow in a microarray analysis (Table S1). To determine 
whether any of these genes act downstream of E4bp4, we 
set up a screen using a complementation approach. E4bp4/ 
lineage-depleted bone marrow was cultured in lymphocyte-
inducing conditions and transduced at 48 h with empty vector 
(negative control), E4bp4 (positive control), or a transcription 
factor of interest before being moved into NK-inducing con-
ditions. E4bp4/ lineage-depleted bone marrow cells did not 
E4bp4 might be a lineage commitment factor controlling the 
development of NKPs from CLPs. In a seminal experiment, 
Pax5 was shown to mediate B cell lineage commitment at 
the pro-B stage by restoring Pax5 expression in Pax5/ 
pro-B cells and examining their ability to produce mature 
B cells (Nutt et al., 1999). To test the hypothesis that E4bp4 
Figure 3. NK development from E4bp4/ CLPs can be rescued by 
restoration of E4bp4 expression. (A–C) LMPPs were sorted from 
E4bp4/ lineage-depleted bone marrow. The phenotype of the cells pre-
sort (A) and postsort (B) is shown. The cells were cultured for 48 h before 
transduction with either MSCV-hCD2 (vector control) or MSCV-hCD2-
E4bp4. The phenotype of the cells at transduction is shown in C. At day 5 
the cells were moved to OP9 stromal cells and IL-15 and cultured for a 
further week. (D–F) Phenotype of cells at the end of culture. Cells were 
gated by scatter and on transduced (hCD2+) cells, excluding OP9 (D). The 
presence of NK cells after transduction with the vector control (E) and E4bp4 
(F) is shown. Data are representative of three independent experiments.
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give rise to NK cells under these conditions, but restoring E4bp4 
expression rescued NK cell production (Fig. 4 A; Gascoyne 
et al., 2009; Kamizono et al., 2009). If a transcription factor 
other than E4bp4 is able to rescue NK cell production in the 
absence of E4bp4, this could indicate that it acts downstream 
of E4bp4.
Eomes effected the most striking rescue, consistently pro-
ducing more NK cells than E4bp4 (mean 3.4-fold change). 
T-bet and Id2 were able to produce NK cells with roughly 
the same efficiency as E4bp4 (mean 0.9-fold change). Gata3, 
Gfi1, Ets1, and Pegasus produced a more modest rescue. Cells 
transduced with Batf3, CEBP, IRF2, MEF, Tox, Foxh1, 
Ifi205, and Lztfl1 did not produce NK cells. The efficiency of 
the rescue effected by each of the transcription factors in the 
screen is shown in Fig. 4 B. As NK production varied between 
assays, the frequency of NK cells produced by the transcrip-
tion factor of interest is normalized to the frequency of NK 
cells in the positive control (E4bp4) condition.
The ability of Eomes, Id2, and T-bet to complement 
E4bp4 suggests that they act downstream in the hierarchy of 
transcription factors controlling NK development. Overex-
pression of E4bp4 in wild-type cells is known to increase NK 
production (Gascoyne et al., 2009), and we found that Eomes, 
Id2, and T-bet had a similar effect, consistent with a position 
downstream of E4bp4 and the law of mass action (Fig. 4 C). 
Additionally, we observed that Eomes and Id2, but not T-bet, 
were expressed at lower levels in E4bp4/ lineage-depleted 
bone marrow cells compared with E4bp4+/+ cells (Fig. 5 A). 
Therefore, E4bp4 seems to promote the expression of Eomes 
and Id2 but not T-bet.
E4bp4 directly regulates the expression of Eomes and Id2
We used chromatin immunoprecipitation (ChIP) to determine 
whether E4bp4 promotes the transcription of Eomes and Id2 
directly by binding in vivo to the regulatory regions of their 
genes. To do this, we took advantage of the new mouse NK-
like cell line MNK-1, which allowed us to use a known E4bp4-
binding site in the regulatory region of the mouse Per2 gene, 
Per2B, as a positive control (Ohno et al., 2007). MNK-1 cells 
were transduced with FLAG-E4bp4, and protein–chromatin 
complexes were immunoprecipitated using either IgG, anti-
FLAG, or one of two polyclonal antibodies to E4bp4.
We searched regulatory regions within 2 kb 5 and 3 of 
the Eomes and Id2 genes and identified six putative E4bp4-
binding sites (Fig. 5 B and Table S2). We examined their enrich-
ment in chromatin immunoprecipitated with anti-FLAG or 
anti-E4bp4 compared with that immunoprecipitated with IgG. 
To rule out the possibility of spurious enrichment, we used 
primers that amplify a region in a gene desert on chromosome 11 
as a negative control. We did not observe enrichment of the 
predicted binding site 5 of Eomes, but we did observe enrich-
ment in one of the predicted binding sites 3 of the gene. For 
Id2, we observed enrichment at the predicted binding site 5 of 
the transcriptional start site but not at either of the binding sites 3 
of the gene (Fig. 5 C). These results indicate that E4bp4 binds 
the regulatory regions controlling Eomes and Id2 transcription 
Figure 4. Identification of transcription factors that comple-
ment the function of E4bp4. (A) E4bp4/ lineage-depleted bone 
marrow cells were cultured in NK-producing conditions and trans-
duced with the indicated MSCV-hCD2 vectors. Cells were gated as in 
Fig. 3 D. The percentage of transduced cells that are NK1.1+ is shown. 
(B) Efficiency of the rescues effected by the 15 cDNAs examined, nor-
malized to that of the positive control (E4bp4). Data are representative 
of five (Eomes and T-bet), four (Id2), three (Gata3, Gfi1, Ets1, and Peg-
asus), or two (Batf3, CEBP, Foxh1, Ifi205, IRF2, Lztfl1, MEF, and Tox) 
independent experiments. Error bars show SEM. (C) E4bp4+/+ lineage-
depleted bone marrow cells were cultured as in A. Data are represen-
tative of two independent experiments.
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iNK, suggesting that Id2, like Eomes, acts at the iNK to mNK 
transition (Boos et al., 2007). The relatively late point at which 
Id2 is required, together with our findings that Id2 is expressed 
later than E4bp4 and that Id2 is a direct transcriptional target 
of E4bp4, places Id2 downstream of E4bp4 in the hierarchy 
of transcription factors controlling NK development. Id2 is 
expressed later than Ets1, is underexpressed in its absence, and 
is a direct target, suggesting that it is also downstream of Ets1 
(Ramirez et al., 2012). The Ets1/ mouse displays a small re-
duction in NKPs (Ramirez et al., 2012), and, although the phe-
notype is less striking than that observed in the E4bp4 knockout, 
the point at which the defect is first observed, together with the 
findings that both E4bp4 and Ets1 directly regulate Id2 tran-
scription, could be consistent with E4bp4 and Ets1 working at 
a similar point upstream of Id2. Therefore, there is mounting 
evidence that Id2 is not as high in the hierarchy of transcription 
factors controlling NK development as previously thought.
Here we have shown that NK-committed progenitors are 
not produced in the absence of E4bp4 and that E4bp4 expres-
sion in CLPs promotes production of NK cells. These findings 
suggest that E4bp4 is required at the NK lineage commitment 
point and hold out the possibility that E4bp4 may even be the 
NK lineage–defining transcription factor. Consistent with a po-
sition for E4bp4 at the top of a hierarchy of transcription factors, 
we have also shown that Eomes and Id2 both act downstream 
in vivo, suggesting that their transcription is regulated by E4bp4. 
To confirm that E4bp4 promotes transcription at these loci, we 
transduced MNK-1 cells with FLAG-E4bp4 and examined 
expression of Eomes and Id2 transcript. Both Eomes and Id2 
increased when E4bp4 was overexpressed (Fig. 5 D), consistent 
with E4bp4 acting as a transactivator at these loci.
Eomes knockout mice die in utero, but experiments using 
conditional knockouts point to its role in mediating the iNK to 
mNK transition (Gordon et al., 2012). Its requirement at this 
point is consistent with a position for Eomes downstream of 
E4bp4. T-bet seems to be required earlier than Eomes, pro-
moting the survival of iNK cells (Townsend et al., 2004; Gordon 
et al., 2012). Both Eomes and T-bet can complement E4bp4. 
This is consistent with both acting downstream of it, but the 
finding that E4bp4 promotes expression of Eomes and not 
T-bet is perhaps at odds with this proposal. One possible expla-
nation is that T-bet, although able to rescue NK cell production 
from E4bp4/ cells, acts in a different pathway from Eomes 
and E4bp4. In support of this, those NK cells that develop in 
the absence of T-bet express Eomes at normal levels (Townsend 
et al., 2004), and there is mounting evidence that Eomes is 
primarily required for NK development in the bone marrow, 
whereas T-bet mediates extramedullary development of NK 
cells (Gordon et al., 2012; Sciumé et al., 2012; Rankin et al., 
2013). The Id2 knockout displays a reduction in mNK but not 
Figure 5. E4bp4 protein directly binds the Eomes and Id2 
loci. (A) Lineage-depleted bone marrow cells from either 
E4bp4+/+ or E4bp4/ mice were cultured for 48 h in lymphocyte-
inducing conditions, and Eomes, Id2, and T-bet transcripts were 
measured (six mice per genotype). *, P < 0.05. (B) Eomes and  
Id2 loci showing the location of the predicted E4bp4-binding 
sites. (C) ChIP analysis of the enrichment of E4bp4 at the  
indicated loci in chromatin from MNK-1 cells transduced with  
5 FLAG–E4bp4. C18 and E16 are polyclonal antibodies to E4bp4, 
and M2 is a monoclonal antibody to FLAG. GD (gene desert) was 
used as a negative control; Per2B was a positive control. (D) MNK-1 
cells were transduced with either vector control or FLAG-E4bp4, 
and expression of Eomes and Id2 transcripts was determined by 
real-time PCR. (C and D) Data are representative of three inde-
pendent biological replicates. Error bars show SEM.
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ChIP. Regulatory regions of Eomes and Id2 were searched for putative 
E4bp4-binding sites using MatInspector (Genomatix) matrix V$E4BP4.01 
nrttayGTAAyu. MNK-1 cells (originating from the laboratory of D.S.J. Allan 
and J.R. Carlyle) were maintained in DMEM supplemented with 10% FCS 
(Gibco), 50 µM -mercaptoethanol, 1 mM sodium pyruvate, and 10 ng/ml 
IL-2 (PeproTech). Lentivirus was produced by transfecting 293T cells with 
pCSGW or pCSGW–5 FLAG–E4bp4 and the packaging plasmids psPAX2 
and pMD2.G (deposited at Addgene as plasmids p12259 and p12260, respec-
tively, by D. Trono, École Polytechnique Fédérale de Lausanne, Lausanne, 
Switzerland). MNK-1 cells were transduced by spinfection at 700 g and 20°C 
for 45 min with 8 µg/ml Polybrene and cultured for a further 48 h before 
cross-linking with 1% formaldehyde and shearing on a Diagenode sonicator 
(5 × 30-s pulses). Protein–DNA complexes were precleared on protein G–
coupled agarose beads (EMD Millipore) before immunoprecipitation with 
IgG (EMD Millipore), M2 antibody to FLAG (Sigma-Aldrich), or polyclonal 
antibodies E4bp4 C18 or E16 (Santa Cruz Biotechnology, Inc.). For each 
sample, 106 cell equivalents of chromatin were incubated with 10 µg anti-
body. Protein G–coupled agarose beads were used to isolate immune com-
plexes, and cross-links were reversed by heating (65°C, 4 h), followed by 
RNase A and proteinase K treatment. DNA was purified on spin columns 
(EMD Millipore) and amplified using ABsolute Blue qPCR SYBR Green 
master mix (Thermo Fisher Scientific) and primers designed to recognize 
putative E4bp4-binding regions (Table S2). The identity of the products was 
confirmed by running on an agarose gel.
Statistical testing. Differences between populations were detected using 
the Mann–Whitney U Test. Where the number of data points was insufficient 
for comparison using nonparametric statistics, no indication of significance 
is shown.
Online supplemental material. Tables S1 and S2 show candidate targets of 
E4bp4 identified by microarray and primers used to amplify putative E4bp4-
binding sites in Eomes and Id2 regulatory regions. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20132398/DC1.
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of E4bp4 and that their transcription is directly regulated by 
E4bp4. Improving our understanding of the molecular basis of 
NK cell development is likely to have practical consequences 
because expression of these core transcription factors could 
have applications in the development of NK-based immuno-
therapies for viral and malignant disease.
MATERIALS AND METHODS
Mice. E4bp4/ mice (Gascoyne et al., 2009) and T-bet/ mice (Townsend 
et al., 2004) were generated as described previously. Rag/ IL15ra/ and 
Rag/ control mice were obtained from the Jackson Laboratory. All ani-
mals used were on a C57BL/6 background, between 6 and 12 wk old, and 
were matched for age and gender. Where possible, littermates were used. 
Animal husbandry and experimental procedures were performed according 
to UK Home Office regulations and institute guidelines.
Flow cytometry. Cells were stained with the following antibodies, all of 
which were anti–mouse and from eBioscience unless otherwise specified: 
2B4 (clone m2B4(B6)458.1; BioLegend), CD2 (RM2-5), CD3 (17A2), 
CD11b (M1/70), CD19 (1D3), CD27 (LG.7F9), CD122 (TM-b1), CD127 
(A7R34), B220 (RA3-6B2), ckit (ACK2), Flt3 (A2F10), Gr1 (RB6-8C5), 
NK1.1 (PK136), Sca1 (D7), Ter119 (TER119), and anti–human CD2 
(RPA-2.10). The lineage cocktail contained B220, CD2, CD11b, Gr1, NK1.1, 
and Ter119. Cells were analyzed on a Fortessa system (BD) or sorted using 
FACSAria (BD).
Microarray analysis. Lin bone marrow cells were obtained from 6 × 
E4bp4+/+ and 6 × E4bp4/ mice, and RNA was extracted using RNeasy 
Micro columns (QIAGEN). RNA was converted to cDNA using the 
Ambion WT Expression kit (Affymetrix), and cDNA was labeled using 
GeneChip WT Terminal Labeling and Controls kit (Affymetrix). The labeled 
cDNA was hybridized to a GeneChip Mouse Gene 1.0 ST Array (Affyme-
trix). The data generated was imported into GeneSpring GXv11 (Agilent 
Technologies) and normalized using the Robust Multi-Array (RMA16) 
algorithm. Genes were filtered on expression value between the 20th and 
100th percentile to remove those with very low or no expression across all 
the samples. A moderated Student’s t test was applied to the data, and p-values 
were adjusted for multiple testing using a Benjamini–Hochberg false discov-
ery rate correction. The microarray data have been deposited in NCBI’s 
Gene Expression Omnibus and are accessible through GEO Series accession 
no. GSE55014.
Real-time PCR. Real-time PCR was performed using TaqMan (Applied 
Biosystems) primer/probe sets recognizing Hprt1 (Mm00446968_m1), E4bp4 
(Nfil3; Mm00600292_s1), Eomes (Mm01351985_m1), Id2 (Mm00711781_m1), 
and T-bet (Tbx21; Mm00450960_m1). Ct values from samples were 
compared with a standard curve made from a known number of mole-
cules of plasmid (E4bp4, Eomes, Id2, and T-bet) or a known number of 
cells (housekeeping control gene Hprt1) to define mRNA expression in 
molecules/cell.
In vitro NK cell development assay. pMSCV constructs were cloned 
as described previously (Gascoyne et al., 2009), and retroviral vectors were 
generated by transfection into LinXE cells. The Gfi1 cDNA was a gift from 
B. Scheijen (Nijmegen Medical Centre, Nijmegen, Netherlands). Total 
Lin bone marrow cells, sorted LMPPs, or CLPs were cultured for 48 h in 
DMEM supplemented with 10% FCS (STEMCELL Technologies), 50 µM 
-mercaptoethanol (Gibco), 10 ng/ml Flt3L (PeproTech), 10 ng/ml IL-7 
(PeproTech), and 100 ng/ml SCF (PeproTech). Cells were transduced either by 
spinfection at 700 g and 20°C for 45 min with 8 µg/ml Polybrene (lineage-
depleted bone marrow) or by addition of the virus with 4 µg/ml Polybrene 
(sorted progenitors) and incubated for a further 72 h. Cells were washed and 
replated at 3 × 104 cells/ml on OP9 stromal cells in -MEM supplemented 
with 20% FCS, -mercaptoethanol, and 30 ng/ml IL-15 (PeproTech). Cells 
were cultured for a further 7 d, with a complete medium change at day 4.
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